Recruiting Idiopathic Thrombocytopenic Purpura Studies in Los Angeles
About Idiopathic Thrombocytopenic Purpura Clinical Trials in Los Angeles
Immune thrombocytopenia (ITP) is an autoimmune condition where the immune system destroys platelets, leading to easy bruising and bleeding. It can occur in children (often self-limiting) or adults (often chronic). Treatment includes corticosteroids, thrombopoietin receptor agonists, and rituximab.
There are currently 7 idiopathic thrombocytopenic purpura clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 614 participants. Research is being sponsored by Takeda, argenx, Eli Lilly and Company and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Idiopathic Thrombocytopenic Purpura Clinical Trials in Los Angeles — FAQ
Are there idiopathic thrombocytopenic purpura clinical trials in Los Angeles?
Yes, there are 7 idiopathic thrombocytopenic purpura clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What idiopathic thrombocytopenic purpura treatments are being tested?
The 7 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for idiopathic thrombocytopenic purpura.
Data updated October 15, 2026 from ClinicalTrials.gov